Showing results (121-130 of 184) with videos related to
Sort By:
Pageof 19
The Journal of Clinical Investigation|December 1, 1989
Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteumH Moncayo, R Moncayo, R Benz, et al.Protein Expression and Purification|March 27, 1999
Removal of N-terminal polyhistidine tags from recombinant proteins using engineered aminopeptidasesJ Pedersen, C Lauritzen, M T Madsen, et al.Plastic and Reconstructive Surgery|July 1, 1996
Dynamic cranioplasty for brachycephalyC Lauritzen, H Friede, A Elander, et al.Zentralblatt Fur Gynakologie|January 1, 1992
[Type and incidence of cytogenetic abnormalities in unfertilized or uncleaved human oocytes within the scope of in vitro fertilization]B Rosenbusch, K Sterzik, V Sasse, et al.Basic & Clinical Pharmacology & Toxicology|December 21, 2005
Effect of itraconazole on the pharmacokinetics of atenololJari J Lilja, Janne T Backman, Pertti J NeuvonenScandinavian Journal of Plastic and Reconstructive Surgery|January 1, 1979
Surgical correction of mandibular prognathism by the oblique sliding osteotomy. A clinical and radiological follow-up study of 112 consecutive casesB Johanson, K E Kahnberg, J Lilja, et al.Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|March 1, 1995
A longitudinal study of speech in 15 children with cleft lip and palate treated by late repair of the hard palateA Lohmander-Agerskov, E Söderpalm, H Friede, et al.Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|June 1, 1996
Delayed closure of the hard palate: a comparison of speech in children with open and functionally closed residual cleftsA Lohmander-Agerskov, H Friede, J Lilja, et al.Clinical Pharmacology and Therapeutics|August 25, 1999
Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatinJ J Lilja, K T Kivistö, P J NeuvonenClinical Pharmacology and Therapeutics|March 6, 2004
Orange juice substantially reduces the bioavailability of the beta-adrenergic-blocking agent celiprololJari J Lilja, Laura Juntti-Patinen, Pertti J NeuvonenPageof 19